JMP Securities Reaffirms Buy Rating for Axon Enterprise (NASDAQ:AXON)

Axon Enterprise (NASDAQ:AXONGet Rating)‘s stock had its “buy” rating reiterated by JMP Securities in a note issued to investors on Wednesday, TipRanks reports. They currently have a $195.00 price objective on the biotechnology company’s stock. JMP Securities’ price target points to a potential upside of 97.23% from the stock’s previous close.

A number of other equities research analysts have also issued reports on AXON. JPMorgan Chase & Co. upgraded Axon Enterprise from a “neutral” rating to an “overweight” rating and dropped their price target for the company from $222.00 to $192.00 in a research report on Friday, February 25th. Zacks Investment Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 19th. Credit Suisse Group initiated coverage on Axon Enterprise in a report on Monday, May 9th. They set an “outperform” rating and a $169.00 price objective on the stock. Morgan Stanley downgraded shares of Axon Enterprise from an “overweight” rating to an “equal weight” rating and set a $120.00 target price for the company. in a research note on Monday, May 23rd. Finally, Needham & Company LLC decreased their target price on shares of Axon Enterprise from $250.00 to $170.00 and set a “buy” rating for the company in a research note on Friday, February 25th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $165.60.

AXON traded down $2.49 during trading on Wednesday, hitting $98.87. 4,047 shares of the stock were exchanged, compared to its average volume of 499,789. The firm has a 50 day simple moving average of $114.87 and a 200 day simple moving average of $135.05. The firm has a market cap of $7.02 billion, a price-to-earnings ratio of 190.50 and a beta of 0.55. Axon Enterprise has a 1 year low of $82.49 and a 1 year high of $209.00. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.18 and a current ratio of 2.43.

Axon Enterprise (NASDAQ:AXONGet Rating) last issued its quarterly earnings results on Tuesday, May 10th. The biotechnology company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.16. The company had revenue of $256.43 million during the quarter, compared to analysts’ expectations of $233.57 million. Axon Enterprise had a return on equity of 3.90% and a net margin of 4.62%. The firm’s revenue was up 31.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.75) EPS. As a group, equities analysts anticipate that Axon Enterprise will post 1.35 earnings per share for the current fiscal year.

In other Axon Enterprise news, CFO Jawad A. Ahsan sold 4,840 shares of Axon Enterprise stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $141.17, for a total value of $683,262.80. Following the transaction, the chief financial officer now owns 360,019 shares in the company, valued at approximately $50,823,882.23. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 6.90% of the stock is owned by company insiders.

Large investors have recently bought and sold shares of the stock. Prospera Financial Services Inc acquired a new position in shares of Axon Enterprise during the 1st quarter valued at $27,000. Retirement Planning Co of New England Inc. acquired a new position in Axon Enterprise in the 4th quarter worth $31,000. Tyler Stone Wealth Management acquired a new position in Axon Enterprise in the 4th quarter worth $32,000. Assetmark Inc. acquired a new position in Axon Enterprise in the 3rd quarter worth $35,000. Finally, Sageworth Trust Co of South Dakota acquired a new position in Axon Enterprise in the 4th quarter worth $37,000. Institutional investors and hedge funds own 72.06% of the company’s stock.

About Axon Enterprise (Get Rating)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.